triphenyltin has been researched along with rosiglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, AH; Mann, KK; Schlezinger, JJ; Yanik, SC | 1 |
| Adomshick, V; Pu, Y; Ticiani, E; Veiga-Lopez, A; White, M | 1 |
2 other study(ies) available for triphenyltin and rosiglitazone
| Article | Year |
|---|---|
Organotins are potent activators of PPARĪ³ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Topics: Adipocytes; Adipogenesis; Animals; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Fatty Acid-Binding Proteins; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Organotin Compounds; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Trialkyltin Compounds | 2011 |
Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes.
Topics: 3T3-L1 Cells; Animals; Cell Differentiation; Mice; PPAR gamma; Rosiglitazone; Trialkyltin Compounds | 2023 |